Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,230 | -11,295 | -4,695 | 1,752 | -23,763 |
| Depreciation Amortization | 1,722 | 1,399 | 948 | 463 | 1,789 |
| Other Working Capital | -2,261 | -1,139 | -1,405 | -586 | 206 |
| Other Operating Activity | 1,468 | 1,135 | 807 | 429 | 1,755 |
| Operating Cash Flow | $-15,301 | $-9,900 | $-4,345 | $2,058 | $-20,013 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,084 | 3,882 | 2,139 | 11,569 | 4,953 |
| PPE Investments | -184 | -185 | -182 | -163 | -28 |
| Investing Cash Flow | $6,900 | $3,697 | $1,957 | $11,406 | $4,925 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,083 | -6,000 | -4,000 | -2,000 | -8,000 |
| Common Stock Issued | 25,226 | 21,144 | 18,785 | 18,779 | 9,336 |
| Other Financing Activity | 0 | 0 | 25 | 0 | 0 |
| Financing Cash Flow | $16,143 | $15,144 | $14,810 | $16,779 | $1,336 |
| Beginning Cash Position | 9,210 | 9,210 | 9,210 | 9,210 | 22,962 |
| End Cash Position | 16,952 | 18,151 | 21,632 | 39,453 | 9,210 |
| Net Cash Flow | $7,742 | $8,941 | $12,422 | $30,243 | $-13,752 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,301 | -9,900 | -4,345 | 2,058 | -20,013 |
| Capital Expenditure | -202 | -197 | -185 | -166 | -79 |
| Free Cash Flow | -15,503 | -10,097 | -4,530 | 1,892 | -20,092 |